2nd study of Gilead's possible COVID-fighting drug in China shut down

The two studies were run by institutions in China; two other controlled clinical trials by Gilead are expected to produce data in early May.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.